首页   按字顺浏览 期刊浏览 卷期浏览 Management of submucous uterine fibroid with buserelin, gemeprost and hysteroscopic res...
Management of submucous uterine fibroid with buserelin, gemeprost and hysteroscopic resection

 

作者: Anthony S Lawrence,   David L Healy,   David Hill,   Peter J Paterson,  

 

期刊: Medical Journal of Australia  (WILEY Available online 1991)
卷期: Volume 154, issue 4  

页码: 280-282

 

ISSN:0025-729X

 

年代: 1991

 

DOI:10.5694/j.1326-5377.1991.tb121094.x

 

出版商: Wiley

 

数据来源: WILEY

 

摘要:

A 19‐year‐old virgin presented with severe menorrhagia and a haemoglobin level of 76 giL as a problem of management. A 5 cm diameter submucous fibroid was identified at hysteroscopy and biopsied but was unable to be removed. The luteinising hormone releasing hormone agonist, buserelin, was used in an attempt to produce symptomatic relief. One week after commencing buserelin therapy, severe menorrhagia occurred and the patient was admitted to hospital with a haemoglobin concentration of 24 giL. Buserelin treatment was continued and no further menstruation occurred over he following year. As the patient was now well, hysteroscopic submucous fibroid resection was contemplated. Due to cervical rigidity in this teenager, a 1 mg gemeprost pessary was inserted into the posterior vaginal fornix three hours before surgery. This allowed an operative hysteroscope to be inserted into the uterus and a fibroid resection to be performed. Menstrual blood loss has been normal for six months after hysteroscopy. A combined medical and surgical approach may avoid hysterectomy in such problem patients.

 

点击下载:  PDF (371KB)



返 回